4WJ-14083-99659
4 vaccinations
7 coded responses
31 check-ins
7 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 902 / CA
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Dose 1 — Pfizer-BioNTech
-
2021-03-19
Registered in v-safe
-
2021-03-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-21
-
2021-03-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-23
-
2021-03-30
Survey response — day 14, dose 1MedDRA: Discomfort — Feeling: Good · Be unable to do your normal daily activitiesFree text: Feeling like i'm trying to function surrounded by quick sandMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-06
-
2021-04-13
Dose 2 — Pfizer-BioNTech
- 2021-04-13
-
2021-04-14
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-20
Health check-in — day 7, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-27
- 2021-05-04
-
2021-05-11
Survey response — day 28, dose 2MedDRA: Hospitalisation, Rash, SARS-CoV-2 test positive, Staphylococcal infection — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Staff infection. Rash on lower right leg. Was hospitalized,but was discharged on 5/9. New covid-19 positive test.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-11
Report sent to call center — day 28, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-18
Survey response — day 35, dose 2MedDRA: Cellulitis, Drug hypersensitivity — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Allergic reaction to cefuroxine taken for cellulitusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-25
-
2021-07-13
Survey response — 3 months, dose 2MedDRA: Anxiety, Depression, Dysphagia, Eye infection, Eye pain, Gastrointestinal disorder, Inflammation — Feeling: Poor · Be unable to work or attend schoolFree text: Inflamation all over, digestive issues, depression and anxiety, trouble swallowing sometimes, eye infections and sorenessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-10-12
-
2021-10-21
Dose 3 — Pfizer-BioNTech
-
2022-02-11
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-04-01
Dose 4 — Pfizer-BioNTech
-
2022-04-13
Survey response — 12 months, dose 2MedDRA: Neuropathy peripheral, Respiratory disorder — Feeling: FairFree text: Some continuing breathing issues. Facial neuropathy.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-21
- 2022-04-22
- 2022-04-29
-
2022-05-06
Survey response — day 35, dose 4MedDRA: Temporomandibular pain and dysfunction syndrome — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I have severe TMJ nowMedDRA releases: 2024-11 · check-in free text available
-
2022-05-06
Report sent to call center — day 35, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-09
-
2022-05-11
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-05-15
- 2022-07-01
- 2022-10-02
- 2023-04-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Pfizer-BioNTech | |
| 2 | 2021-04-13 | Pfizer-BioNTech | |
| 3 | 2021-10-21 | Pfizer-BioNTech | No |
| 4 | 2022-04-01 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 6 — day 14, dose 1
Symptoms: Feeling like i'm trying to function surrounded by quick sand
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Sore throat
Release 8 — day 28, dose 2
Symptoms: Staff infection. Rash on lower right leg. Was hospitalized,but was discharged on 5/9. New covid-19 positive test.
Release 8 — day 35, dose 2
Symptoms: Allergic reaction to cefuroxine taken for cellulitus
Release 9 — 3 months, dose 2
Symptoms: Inflamation all over, digestive issues, depression and anxiety, trouble swallowing sometimes, eye infections and soreness
Release 11 — 12 months, dose 2
Symptoms: Some continuing breathing issues. Facial neuropathy.
Release 11 — day 35, dose 4
Symptoms: I have severe TMJ now
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anxiety | ✓ | ✓ | ✓ |
| SD | Cellulitis | ✓ | ✓ | ✓ |
| SD | Depression | ✓ | ✓ | ✓ |
| SD | Discomfort | ✓ | ✓ | ✓ |
| SD | Drug hypersensitivity | ✓ | ✓ | ✓ |
| SD | Dysphagia | ✓ | ✓ | ✓ |
| SD | Eye infection | ✓ | ✓ | ✓ |
| SD | Eye pain | ✓ | ✓ | ✓ |
| SD | Gastrointestinal disorder | ✓ | ✓ | ✓ |
| SD | Hospitalisation | ✓ | ✓ | ✓ |
| SD | Inflammation | ✓ | ✓ | ✓ |
| SD | Neuropathy peripheral | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Respiratory disorder | · | · | ✓ |
| SD | SARS-CoV-2 test positive | ✓ | ✓ | ✓ |
| SD | Staphylococcal infection | ✓ | ✓ | ✓ |
| SD | Temporomandibular pain and dysfunction syndrome | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release